v3.25.3
CONDENSED STATEMENTS OF CONSOLIDATED CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   631,000,000      
Beginning balance at Dec. 31, 2023   $ 6 $ 8,604 $ 1,092 $ (35)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   19,000,000      
Issuances of Common Stock, net of issuance costs   $ 0 494    
Issuances related to benefit and investment plans (in shares)   2,000,000      
Issuances related to benefit and investment plans   $ 0 (7)    
Net income $ 771     771  
Common Stock dividends declared (see Note 15)       (395)  
Other comprehensive income (loss) 5       5
Ending balance (in shares) at Sep. 30, 2024   652,000,000      
Ending balance at Sep. 30, 2024 10,535 $ 6 9,091 1,468 (30)
Beginning balance (in shares) at Jun. 30, 2024   642,000,000      
Beginning balance at Jun. 30, 2024   $ 6 8,836 1,542 (30)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   10,000,000      
Issuances of Common Stock, net of issuance costs   $ 0 247    
Issuances related to benefit and investment plans (in shares)   0      
Issuances related to benefit and investment plans   $ 0 8    
Net income 193     193  
Common Stock dividends declared (see Note 15)       (267)  
Other comprehensive income (loss) 0       0
Ending balance (in shares) at Sep. 30, 2024   652,000,000      
Ending balance at Sep. 30, 2024 $ 10,535 $ 6 9,091 1,468 (30)
Beginning balance (in shares) at Dec. 31, 2024 651,727,276 652,000,000      
Beginning balance at Dec. 31, 2024 $ 10,666 $ 6 9,105 1,572 (17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   0      
Issuances of Common Stock, net of issuance costs   $ 0 0    
Issuances related to benefit and investment plans (in shares)   1,000,000      
Issuances related to benefit and investment plans   $ 0 14    
Net income 788     788  
Common Stock dividends declared (see Note 15)       (431)  
Other comprehensive income (loss) $ (2)       (2)
Ending balance (in shares) at Sep. 30, 2025 652,865,523 653,000,000      
Ending balance at Sep. 30, 2025 $ 11,035 $ 6 9,119 1,929 (19)
Beginning balance (in shares) at Jun. 30, 2025   653,000,000      
Beginning balance at Jun. 30, 2025   $ 6 9,107 1,923 (17)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of Common Stock, net of issuance costs (in shares)   0      
Issuances of Common Stock, net of issuance costs   $ 0 0    
Issuances related to benefit and investment plans (in shares)   0      
Issuances related to benefit and investment plans   $ 0 12    
Net income 293     293  
Common Stock dividends declared (see Note 15)       (287)  
Other comprehensive income (loss) $ (2)       (2)
Ending balance (in shares) at Sep. 30, 2025 652,865,523 653,000,000      
Ending balance at Sep. 30, 2025 $ 11,035 $ 6 $ 9,119 $ 1,929 $ (19)